Search results for

Food and Drug Commissioner Scott Gottlieb says he wants to know why drugmakers churn out medicines for some rare diseases but not others.

In California, the flu has struck early and hard this season. Health experts aren't sure why. The state's higher temperatures typically result in a later flu peak there than in other parts of the U.S.

Some knocks on the Affordable Care Act are ideological. Others are misunderstandings. People who make too much to qualify for subsidies to defray their mandated insurance purchases have suffered.

Based on research conducted at the University of Michigan, surgeons developed a simple strategy to reduce misuse and abuse of painkillers after surgery: give patients fewer pills.

As a patient, a critically ill doctor witnesses communication lapses, uncoordinated care and lack of empathy from her health care providers and vows to improve the patient experience for others.

As the number of immigrants available for farm work has dwindled in California, many who are left are older, and suffer from health problems related to decades of difficult labor.

For a small percentage of people who smoke marijuana, long-term use can make them sick with violent vomiting. California doctors worry they'll see more cases when pot is fully legalized in January.

The Republican tax plan could reduce or eliminate federal tax credits that reward companies for developing drugs to treat rare diseases. People who benefit from the medicines have objected.

The Pharmaceutical Research and Manufacturers of America, the brand-name drug industry's main trade group, spent liberally to shift the conversation on prices during the last presidential campaign.

Some people looking for 2018 insurance under the Affordable Care Act may have a little longer to sign up — for example, in states and U.S. territories hit by this year's hurricanes.